KR is a 22 y/o female, 210lbs, no known allergies, and you are preparing to prescribe her contraception. She has a strong family history for osteoporosis. She is not on any medications but states she had a very hard time remembering to take pills. She is not interested in getting pregnant for at least 3 years or more. Which mode of delivery would be the best for KR? Select one:

Contraceptive selection should consider effectiveness, duration of action, patient adherence, comorbid risks, and future pregnancy plans. Long-acting reversible contraception is often preferred for patients who have difficulty remembering daily medications and who desire reliable pregnancy prevention for several years. Family history and medication side effects must also be considered when choosing the safest option. In this case, bone health and adherence are important factors guiding the best contraceptive choice. Rationale: A. Norethindrone tablets require strict daily adherence at nearly the same time each day to maintain contraceptive effectiveness. Since the patient reports difficulty remembering pills, this option would increase the risk of missed doses and unintended pregnancy. Although it avoids estrogen-related concerns, poor adherence makes it a less suitable long-term choice for this patient. B. Etonogestrel implant (Nexplanon) is the best option because it provides highly effective contraception for up to 3 years with a single placement and requires no daily or frequent maintenance. It is ideal for patients who struggle with medication adherence and want long-term pregnancy prevention. It also avoids the bone mineral density concerns associated with depot medroxyprogesterone, making it more appropriate given her strong family history of osteoporosis. C. Medroxyprogesterone (Depo-Provera) is effective and does not require daily adherence, but long-term use is associated with decreased bone mineral density. Since the patient has a strong family history of osteoporosis, this is less desirable, especially when safer long-acting alternatives are available. The need for repeat injections every 3 months also adds maintenance requirements compared to an implant. D. Ethinyl estradiol and norelgestromin patch (Xulane) requires weekly application and consistent replacement to remain effective. While easier than daily pills, it still depends on regular patient adherence. In addition, contraceptive patch effectiveness may be reduced in patients with higher body weight, and at 210 pounds, this may reduce reliability compared to a long-acting implant option.